002873 新天药业
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)2.8507.23611.09811.6049.457
总资产报酬率 ROA (%)1.6004.3126.6306.5015.539
投入资产回报率 ROIC (%)1.7514.7757.4527.2386.110

边际利润分析
销售毛利率 (%)74.69177.06977.26579.25977.984
营业利润率 (%)8.5309.82611.20912.04811.474
息税前利润/营业总收入 (%)10.97510.94612.18313.74211.903
净利润/营业总收入 (%)6.8698.47710.25310.2579.661

收益指标分析
经营活动净收益/利润总额(%)105.52789.83599.25395.48196.211
价值变动净收益/利润总额(%)0.011-0.784-0.3260.0000.000
营业外收支净额/利润总额(%)-4.466-1.435-0.472-0.400-2.883

偿债能力分析
流动比率 (X)0.9171.1461.2171.3221.578
速动比率 (X)0.6580.8140.8521.0541.409
资产负债率 (%)45.99841.76539.00941.76546.173
带息债务/全部投入资本 (%)38.40433.04128.55930.90138.913
股东权益/带息债务 (%)152.735194.359237.615214.444150.773
股东权益/负债合计 (%)117.400139.433156.348139.438116.575
利息保障倍数 (X)3.9068.69811.8667.88815.850

营运能力分析
应收账款周转天数 (天)105.94986.68875.42574.53289.581
存货周转天数 (天)281.315302.535219.909183.968196.910